Alphaf-001 is under clinical development by Alpha Fusion and currently in Phase I for Follicular Thyroid Cancer.

The therapeutic candidate is under development for the treatment of ovarian cancer. It comprises of induced pluripotent stem (iPS) cell derived natural killer (iNK) cell.

In recent years, the oil and gas industry has progressed from using digital technologies for select use cases to making their ...

The surge in machinery patents is driven by the need for technological innovation to improve excavation processes.

Lilly’s offering is expected to surpass Novo’s Wegovy in the space, and, according to a report this week from GlobalData, it ...

Operational risks are also reduced due to a lesser need for human intervention in hazardous environments, which is a very ...

It’s become evident that a cloud-based IT portfolio brings organisations the greatest promise for providing the type of ...

The “Instrument and Electrical Reliability Engineering (I&E RE)” position in Chevron’s ENGINE Centre (located in Bengaluru, ...

In a release sent to Rigzone recently, GlobalData said the oil and gas industry has seen a dip in active jobs in 2024 but ...

Big Lots has been handed a lifeline by Gordon Brothers Retail Partners and Variety Wholesalers to save some 200 to 400 stores ...